慢性中央血清性胆色素变异症的两个病例成功地用系统性干扰素α治疗
Lingling Huang1, Christina Flaxel1, Eric Suhler1,2
1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
Ocular immunology and inflammation
|July 14, 2023
概括
干扰素α为慢性中央血清性胆色素变异症 (CSCR) 提供了一个有前途的新疗法,这是一个危及视力的疾病. 这种方法在传统疗法面临短缺和可变疗效的情况下显示出潜力.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 医疗治疗 医疗治疗
背景情况:
- 慢性中央血清性胆色素变异症 (CSCR) 是一种严重的疾病,可能导致法律失明.
- 目前的主要治疗方法,白素光动力疗法,因全球缺乏而受到限制.
- 替代治疗方法在慢性CSCR方面表现出不一致的有效性.
研究的目的:
- 调查干扰素α作为耐火性慢性CSCR治疗的疗效.
- 报告用干扰素α治疗的患者的解剖学和功能结果.
主要方法:
- 两例耐治疗慢性CSCR病例通过皮下干扰素α注射得到治疗.
- 临床结果的评估是基于解剖学和功能性改善.
主要成果:
- 两位患有慢性CSCR的患者在干扰素α治疗后都经历了显著的解剖和功能恢复.
- 这代表了第一个报告的系统性干扰素α用于慢性CSCR的使用.
结论:
- 系统性干扰素α证明了慢性CSCR的治疗潜力,特别是在对其他治疗不耐药的情况下.
- 通过随机对照试验进行进一步的研究是有必要的,以确认PEG-IFNα2a的安全性,有效性和慢性CSCR的最佳剂量.
相关概念视频
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Angle Closure Glaucoma: Treatment
574
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
574


